يعرض 1 - 10 نتائج من 248 نتيجة بحث عن '"enfermedad arterial coronaria"', وقت الاستعلام: 1.18s تنقيح النتائج
  1. 1
    رسالة جامعية

    المؤلفون: Carrillo Suárez, Xavier

    المساهمون: University/Department: Universitat Autònoma de Barcelona. Departament de Medicina

    مرشدي الرسالة: Bayés Genís, Antoni

    المصدر: TDX (Tesis Doctorals en Xarxa)

    الوقت: 616.1

    وصف الملف: application/pdf

  2. 2
    دورية أكاديمية
  3. 3
    دورية أكاديمية
  4. 4
    دورية أكاديمية
  5. 5
    دورية أكاديمية
  6. 6
  7. 7
  8. 8
    دورية أكاديمية
  9. 9
    دورية أكاديمية
  10. 10
    دورية أكاديمية

    المصدر: Revista Información Científica; Vol. 102 (2023); 4108 ; 1028-9933

    وصف الملف: application/pdf; application/xml; application/epub+zip

    العلاقة: https://revinfcientifica.sld.cu/index.php/ric/article/view/4108/5624Test; https://revinfcientifica.sld.cu/index.php/ric/article/view/4108/5744Test; https://revinfcientifica.sld.cu/index.php/ric/article/view/4108/5666Test; https://revinfcientifica.sld.cu/index.php/ric/article/view/4108/5626Test; https://revinfcientifica.sld.cu/index.php/ric/article/view/4108/5746Test; https://revinfcientifica.sld.cu/index.php/ric/article/view/4108/5636Test; Fox KAA, Metra M, Morais J, Atar D. The myth of ‘stable’ coronary artery disease. Nat Rev Cardiol [Internet]. 2020 [citado 20 Dic 2022]; 17(1):9-21. Disponible en: https://www.nature.com/articles/s41569-019-0233-yTest; Stone GW, Maehara A, Lansky AJ, de Bruyne B, Cristea E, Mintz GS, et al. A Prospective Natural-History Study of Coronary Atherosclerosis. N Engl J Med [Internet]. 2011 [citado 20 Dic 2022]; 364(3):226-35. DOI: https://doi.org/10.1056/nejmoa1002358Test; Cannon CP, Blazing MA, Giugliano RP, McCagg A, White JA, Theroux P, et al. Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes. N Engl J Med [Internet]. 2015 [citado 20 Dic 2022]; 372(25):2387-97. DOI: https://doi.org/10.1056/nejmoa1410489Test; Katritsis DG, et al. Guía ESC 2019 sobre el tratamiento de pacientes con taquicardia supraventricular. Rev Esp Cardiol [Internet]. 2020 Jun [citado 20 Dic 2022]; 73(6):496.e1-496.e60. DOI: https://doi.org/10.1016/j.recesp.2019.12.029Test; Eisen A, Bhatt DL, Steg PG, Eagle KA, Goto S, Guo J, et al. Angina and future cardiovascular events in stable patients with coronary artery disease: Insights from the Reduction of Atherothrombosis for Continued Health (REACH) Registry. J Am Heart Assoc [Internet]. 2016 [citado 20 Dic 2022]; 5(10). DOI: https://doi.org/10.1161/JAHA.116.004080Test; Zinman B, Wanner C, Lachin JM, Fitchett D, Bluhmki E, Hantel S, et al. Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes. N Engl J Med [Internet]. 2015 [citado 20 Dic 2022]; 373(22):17-28. DOI: https://doi.org/10.1056/nejmoa1504720Test; Marso SP, Daniels GH, Brown-Frandsen K, Kristensen P, Mann JFE, Nauck MA, et al. Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes. N Engl J Med [Internet]. 2016 [citado 20 Dic 2022]; 375(4):311-22. DOI: https://doi.org/10.1056/nejmoa1603827Test; Marso SP, Bain SC, Consoli A, Eliaschewitz FG, Jódar E, Leiter LA, et al. Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes. N Engl J Med [Internet]. 2016 [citado 20 Dic 2022]; 375(19):1834-1844. Disponible en: https://doi.org/10.1056/nejmoa1607141Test; https://revinfcientifica.sld.cu/index.php/ric/article/view/4108Test